---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-003156"
form_type: "8-K"
ticker: "ADCT"
cik: "0001771910"
company_name: "ADC Therapeutics SA"
filed_at: "2024-02-29T23:59:59+00:00"
generated_at: "2026-06-05T07:09:49.250161+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# ADC Therapeutics SA Board approves Annual Bonus Plan for 2024

## Summary
- Plan effective retroactively from Jan 1, 2024; bonuses based on corporate objectives approved by Board or Compensation Committee.
- Eligible participants: full-time and part-time regular employees in good standing, including named executive officers.
- Target bonus expressed as percentage of base salary; payout determined after year-end per payout curve for each objective.
- Payment to be made on or before March 15 (US) or end of March (other countries); prorated for new hires, transfers, leaves.

## SEC filing metadata
- accession: 0000950103-24-003156
- form_type: 8-K
- ticker: ADCT
- cik: 0001771910
- company_name: ADC Therapeutics SA
- filed_at: 2024-02-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771910/000095010324003156/0000950103-24-003156-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771910/000095010324003156/dp207290_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-003156
- JSON: https://secwatch.observer/filing/0000950103-24-003156.json
- Plain text: https://secwatch.observer/filing/0000950103-24-003156.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.